Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants

Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants

IntroductionRotavirus-associated diarrheal diseases significantly burden healthcare systems, particularly affecting infants under five years. Both Rotarix™ (RV1) and RotaTeq™ (RV5) vaccines have been effective but have distinct application schedules and limited interchangeability data. This study ai...

Full description

Bibliographic Details
Main Authors: Mercedes Macías-Parra, Patricia Vidal-Vázquez, Jesús Reyna-Figueroa, Miguel Ángel Rodríguez-Weber, Hortensia Moreno-Macías, Inés Hernández-Benavides, Sofía Fortes-Gutiérrez, Vesta Louise Richardson, Paola Vázquez-Cárdenas
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Public Health
Subjects:
rotavirus
vaccine interchangeability
RV1
RV5
immunogenicity
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2024.1356932/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2024.1356932/full

Similar Items